References
Fox AW. The pharmaceutical year that was, 2016. Pharm Med. 2016;30:317–9.
Tovey A. Drug firms may face big damages bill from NHS for overcharging. Daily Telegraph 2016 Dec 8, Business, p 1.
Towse A. The UK pharmaceutical market. An overview. Pharmacoeconomics. 1996;10(suppl 2):14–25.
Visco F. Fruitless drug research. NY Times. 2017;3:A20.
Slamon D, Eierman W, Robert N, et al. Adjuvant trastuzumab in HER-2 positive breast cancer. N Engl J Med. 2011;365:1273–83.
Lenzer J. Big data’s big bias: bringing noise and conflicts to US drug regulation. BMJ. 2017;358:j3275.
Deutsch K. Fentanyl outpaces heroin as the deadliest drug on Long Island. NY Times. 2016;29:A18–9.
McCarthy M. How inappropriate prescribing prompted the opioid addiction ravaging small town America. BMJ. 2017;359:j4730.
Makary MA, Overton HN, Wang P. Overprescribing is major contributor to opioid crisis. BMJ. 2017;359:j4792.
Bodkin H. Drug firms sue watchdog over price cap on medicines. Daily Telegr. 2017;11:6.
Withers I. Foreign drug giants behind challenge to NHS rationing. Daily Telegr. 2017;15:9.
European Medicines Agency. EMA working group on committees’ operational preparedness for human medicines. EMA/300951/2017. London: EMA; 2017.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Funding
No funding was provided for the publication of this work.
Conflict of interest
Tony Fox declares that he holds no stock in any company that is marketing pharmaceutical products, and he has had no emoluments, of any type, from such a company during at least the past 5 years.
Rights and permissions
About this article
Cite this article
Fox, A.W. The Pharmaceutical Year That Was, 2017. Pharm Med 31, 379–382 (2017). https://doi.org/10.1007/s40290-017-0214-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40290-017-0214-6